DrugDashboards

Market view

mesalamine · Powder

46 marketed package NDCs · 22 active manufacturers

Most dispensed: 1.2 g · Tablet, Delayed Release · #120 tablet, delayed releases/bottle · .375 g · Capsule, Extended Release · #120 capsule, extended releases/bottle · 800 mg · Tablet, Delayed Release · #180 tablet, delayed releases/bottle · 1000 mg · Suppository · #5 packages/carton / 6 suppository in 1 package

The short version

22 companies supply this market — deep enough that no single failure threatens the supply.

What changed in the last 90 days

Every detected change for mesalamine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • MesalamineAug 27, 2026
    New shortageby this manufacturer
    Mylan Pharmaceuticals Inc., a Viatris Company's Mesalamine (Capsule, Extended Release, .375 g) is newly in shortage61 companies market mesalamine
  • MesalamineAug 19, 2026
    Price down
    NADAC $0.81924 → $0.79534 per unit (-2.92%)
  • MesalamineAug 19, 2026
    Price down
    NADAC $0.09966 → $0.09744 per unit (-2.23%)
  • MesalamineAug 19, 2026
    Price down
    NADAC $1.30434 → $1.2867 per unit (-1.35%)
  • Mesalamine RectalAug 19, 2026
    Price down
    NADAC $1.30434 → $1.2867 per unit (-1.35%)
  • mesalamineAug 19, 2026
    Price down
    NADAC $0.81924 → $0.79534 per unit (-2.92%)
  • MesalamineAug 19, 2026
    Price up
    NADAC $0.4832 → $0.48654 per unit (+0.69%)
  • mesalamineAug 19, 2026
    Price down
    NADAC $4.08413 → $4.0027 per unit (-1.99%)
  • MesalamineAug 19, 2026
    Price up
    NADAC $0.4832 → $0.48654 per unit (+0.69%)
  • MesalamineAug 19, 2026
    Price down
    NADAC $4.08413 → $4.0027 per unit (-1.99%)

Same drug class

Other molecules FDA puts in Aminosalicylate, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Mesalamine in shortage right now?
No. FDA does not currently list Mesalamine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Mesalamine?
61 companies have marketed Mesalamine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Mesalamine cost?
The typical pharmacy pays about $0.7953 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.